When Did the FDA Approve Paxlovid for COVID-19 Treatment?

Learn the FDA approval date of Paxlovid for emergency use in treating COVID-19 high-risk patients and where to find updated information.

44 views

The FDA approved Paxlovid on December 22, 2021 for emergency use to treat COVID-19 in high-risk patients. For the most current information, consult your healthcare provider or visit official health websites.

FAQs & Answers

  1. What is Paxlovid and how does it work? Paxlovid is an antiviral medication approved to treat COVID-19 by preventing the virus from replicating in high-risk patients.
  2. Who is eligible to use Paxlovid under FDA guidelines? Paxlovid is authorized for emergency use to treat COVID-19 patients who are at high risk for progressing to severe illness.
  3. Where can I find the most current information about Paxlovid? Current updates about Paxlovid can be found through your healthcare provider or official health websites such as the FDA or CDC.

Watch More

For more information on COVID-19 treatments and updates on FDA approvals, explore our related videos covering antiviral medications, vaccine developments, and patient safety guidelines.

  1. What Defines Fully Vaccinated Status in the US? Discover what it means to be fully vaccinated in the US, including vaccine types and booster shot recommendations.
  2. What's New in COVID Vaccines: Updated Pfizer-BioNTech Booster Explained Discover the latest COVID vaccine: the updated Pfizer-BioNTech bivalent booster for 2023.